Prodromal dementia is largely underdiagnosed in primary care.
Objective
To develop a clinical model for detecting prodromal dementia within the operative boundaries of primary care practice.
Methods
The study employed the Functional Activities Questionnaire (FAQ) and Montreal Cognitive Assessment (MoCA) to evaluate a “functional-cognitive” step-down screening model, in which the MoCA is administered subsequent to reported symptoms on the FAQ. It classified participants from the Alzheimer's Disease Imaging Initiative to three diagnostic categories: (1) healthy cognition (n = 396), (2) mild cognitive impairment without conversion (n = 430), and (3) prodromal dementia assessed 24 months before diagnosis (n = 164).
Results
Analyses indicated that the step-down model (Model 1) performed significantly better than an alternative model that applied the FAQ as a single measure (Model 2) and compared well with another model that administered both screening measures to all participants (Model 3). Gradient Boosting Trees classifications yielded the following estimations for Model 1/Model 2/ Model 3, respectively: Sensitivity = 0.87/0.77/0.89, Specificity = 0.68/0.47/0.70, PPV = 0.73/0.40/0.75, NVP = 0.84/0.81/0.87, F1 Score = 0.79/0.52/0.81, AUC = 0.78/0.67/0.79.
Conclusions
These analyses support the proposed model. The study offers algorithms for validated measures, which were developed from a well characterized clinical sample. Their accuracy will likely improve further with new data from diverse clinical settings. These results can serve primary care in a timely manner in light of the recent advances in pharmacological treatment of dementia and the expected increase in demand for screening.
US Preventive Services Task Force. Screening for cognitive impairment in older adults: US preventive services task force recommendation statement. JAMA2020; 323: 757–763.
CordellCBBorsonSBoustaniM, et al.Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare annual wellness visit in a primary care setting. Alzheimers Dement2013; 9: 141–150.
5.
BelloVMESchultzRR. Prevalence of treatable and reversible dementias: a study in a dementia outpatient clinic. Dement Neuropsychol2011; 5: 44–47.
6.
BaumgartMSnyderHMCarrilloMC, et al.Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement2015; 11: 718–726.
7.
NganduTLehtisaloJSolomonA, et al.A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet2015; 385: 2255–2263.
RasmussenJLangermanH. Alzheimer's disease - why we need early diagnosis. Degener Neurol Neuromuscul Dis2019; 9: 123–130.
10.
RobinsonLTangETaylorJ. Dementia: timely diagnosis and early intervention. BMJ2015; 350: h3029.
11.
de VugtMEVerheyFR. The impact of early dementia diagnosis and intervention on informal caregivers. Prog Neurobiol2013; 110: 54–62.
12.
FoldesSSMoriartyJPFarsethPH, et al.Medicaid savings from the New York University caregiver intervention for families with dementia. Gerontologist2018; 58: e97–e106.
13.
BanerjeeSWittenbergR. Clinical and cost effectiveness of services for early diagnosis and intervention in dementia. Int J Geriatr Psychiatry2009; 24: 748–754.
14.
WeimerDLSagerMA. Early identification and treatment of Alzheimer’s disease: social and fiscal outcomes. Alzheimers Dement2009; 5: 215–226.
15.
DuboisBPadovaniAScheltensP, et al.Timely diagnosis for Alzheimer’s disease: a literature review on benefits and challenges. J Alzheimers Dis2016; 49: 617–631.
16.
BaronRJ. What's keeping us so busy in primary care? A snapshot from one practice. N Engl J Med2010; 362: 1632–1636.
17.
Tai-SealeMMcGuireTGZhangW. Time allocation in primary care office visits. Health Serv Res2007; 42: 1871–1894.
18.
PorterJBoydCSkandariMR, et al.Revisiting the time needed to provide adult primary care. J Gen Intern Med2023; 38: 147–155.
19.
YarnallKSHPollakKIØstbyeT, et al.Primary care: is there enough time for prevention?Am J Public Health2003; 93: 635–641.
20.
PrivettNGuerrierS. Estimation of the time needed to deliver the 2020 USPSTF preventive care recommendations in primary care. Am J Public Health2021; 111: 145–149.
21.
ØstbyeTYarnallKSHKrauseKM, et al.Is there time for management of patients with chronic diseases in primary care?Ann Fam Med2005; 3: 209–214.
22.
BarnesDEZhouJWalkerRL, et al.Development and validation of eRADAR: a tool using EHR data to detect unrecognized dementia. J Am Geriatr Soc2020; 68: 103–111.
23.
KallumpuramSSudhir KumarCKhanB, et al.Targeted case finding for dementia in primary care: surrey downs dementia diagnosis project. BMJ Qual Improv Rep2015; 4: u209827.w4086.
24.
GonzálezDAGonzalesMMJennetteKJ, et al.Cognitive screening with functional assessment improves diagnostic accuracy and attenuates bias. Alzheimers Dement (Amst)2021; 13: e12250.
25.
SteenlandNKAumanCMPatelPM, et al.Development of a rapid screening instrument for mild cognitive impairment and undiagnosed dementia. J Alzheimers Dis2008; 15: 419–427.
26.
TappenRMRosselliMEngstromG. Use of the MC-FAQ and MMSE-FAQ in cognitive screening of older African Americans, Hispanic Americans, and European Americans. Am J Geriatr Psychiatry2012; 20: 955–962.
27.
YemmHRobinsonDLPaddickSM, et al.Instrumental activities of daily living scales to detect cognitive impairment and dementia in low- and middle-income countries: a systematic review. J Alzheimers Dis2021; 83: 451–474.
28.
GonzálezDAGonzalesMMReschZJ, et al.Comprehensive evaluation of the functional activities questionnaire (FAQ) and its reliability and validity. Assessment2022; 29: 748–763.
29.
BruijnenCJWHDijkstraBAGWalvoortSJW, et al.Psychometric properties of the Montreal Cognitive Assessment (MoCA) in healthy participants aged 18–70. Int J Psychiatry Clin Pract2020; 24: 293–300.
30.
DanielBAgenagnewLWorkichoA, et al.Psychometric properties of the Montreal Cognitive Assessment (MoCA) to detect major neurocognitive disorder among older people in Ethiopia: a validation study. Neuropsychiatr Dis Treat2022; 18: 1789–1798.
31.
SalaGInagakiHIshiokaYL, et al.Psychometric properties of the montreal cognitive assessment (MOCA): a comprehensive investigation. Swiss J Psychol2019; 79: 155–161.
32.
SchmidtM. Rey auditory verbal learning test: A handbook. Los Angeles, CA: Western Psychological Services, 1996.
33.
de Sousa MagalhãesSFernandes Malloy-DinizLCavalheiro HamdanA. Validity convergent and reliability test-retest of the Rey Auditory Verbal Learning Test. Clin Neuropsychiatry2012; 9: 129–137.
34.
MoradiEHallikainenIHänninenT, et al.Rey's auditory verbal learning test scores can be predicted from whole brain MRI in Alzheimer's disease. Neuroimage Clin2016; 13: 415–427.
35.
WilcoxRR. Introduction to robust estimation and hypothesis testing. Cambridge, MA: Academic Press, 2021.
36.
HackettKMisRDrabickDAG, et al.Informant reporting in mild cognitive impairment: sources of discrepancy on the functional activities questionnaire. J Int Neuropsychol Soc2020; 26: 503–514.
37.
GonzálezDAClarkMJGonzalesMM, et al.An evaluation of item bias on the functional activities questionnaire. Arch Clin Neuropsychol2023; 38: 276–282.
38.
LevyBTsoyEGableS. Developing cognitive markers of Alzheimer's disease for primary care: implications for behavioral and global prevention. J Alzheimers Dis2016; 54: 1259–1272.
39.
PaisMVForlenzaOVDinizBS. Plasma biomarkers of Alzheimer's disease: a review of available assays, recent developments, and implications for clinical practice. J Alzheimers Dis Rep2023; 7: 355–380.
40.
GalvinJEValoisLZweigY. Collaborative transdisciplinary team approach for dementia care. Neurodegener Dis Manag2014; 4: 455–469.
41.
CallahanCMBoustaniMAUnverzagtFW, et al.Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA2006; 295: 2148–2157.
42.
HeintzHMonettePEpstein-LubowG, et al.Emerging collaborative care models for dementia care in the primary care setting: a narrative review. Am J Geriatr Psychiatry2020; 28: 320–330.
43.
GreavesIGreavesNWalkerE, et al.Gnosall primary care memory clinic: eldercare facilitator role description and development. Dementia2015; 14: 389–408.
